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Background: MTHFR 677C>T polymorphism is a genetic alteration in an enzyme involved in folate metabolism, but
its effect on host susceptibility to cervical cancer is still uncertain. The aim of this study was to investigate the
association between MTHFR 677C>T polymorphism and cervical cancer by performing a meta-analysis.
Methods: Pubmed, Embase, Web of Science, and the Chinese Biomedical Database (CBM) databases were searched
for case–control studies investigating the association between MTHFR 677C>T polymorphism and cervical cancer.
Odds ratios (OR) and 95% confidence intervals (95%CI) were used to assess this possible association.
Results: 11 studies with a total of 1898 cervical cancer cases and 2678 controls were included. Meta-analyses of a
total 11 studies showed no association between MTHFR 677C>T polymorphism and cervical cancer using all five
genetic models (All P values > 0.05). However, subgroup analyses showed the odds of the homozygous TT
genotype were much less in cervical cancer cases than in controls in Europeans, which implied an association
between the homozygous TT genotype and cervical cancer in Europeans (For TT versus CC, fixed-effects OR = 0.65,
95%CI 0.45-0.93, P = 0.020, I2 = 0.0%). The odds for the homozygous TT genotype were greater in cervical cancer
cases than in controls in East Asians, which also implied an association between the homozygous TT genotype and
cervical cancer in East Asians (For TT versus CC, random-effects OR = 1.66, 95%CI 1.05-2.62, P = 0.029, I2 = 52.6%; For
TT versus CT/CC, random-effects OR = 1.55, 95%CI 1.09-2.22, P = 0.016, I2 = 42.4%). Both subgroup analyses and
meta-regression analyses suggested ethnicity was the major source of heterogeneity. Publication bias was not evident.
Conclusions: This meta-analysis supports an association between MTHFR 677C>T polymorphism and cervical cancer,
and the effect of this association may be race specific. Further studies with large sample sizes and careful design are
needed to identify this association more comprehensively.
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Cervical cancer is the third most commonly diagnosed
cancer and the fourth leading cause of cancer death in
women worldwide [1]. Global cervical cancer incidence
increased from 378,000 cases per year in 1980 to 454,000
cases per year in 2010, and killed 200,000 women in
2010. Of these, 46,000 were found in developing coun-
tries in the 15–49 year old age bracket [2]. Though there
have been many advances in the classification, diagnosis* Correspondence: tmmuliangzq@yahoo.cn
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reproduction in any medium, provided the orand treatment of cervical cancer, it is still a public health
concern [2]. The mechanism of cervical carcinogenesis
remains unclear, and multiple environmental and lifestyle
factors may increase the risk of developing cervical
cancer, including human papilloma virus (HPV) [3,4]. How-
ever, not all of those subjects exposed to these risk
factors develop cervical cancer, which suggests genetic
factors may also play an important role in the host's sus-
ceptibility to the disease.
Methylenetetrahydrofolate reductase (MTHFR) converts
5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate
and directs the homeostasis between DNA synthesis
and methylation [5]. The MTHFR 677C>T (rs1801133). This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to Valine and decreases the MTHFR enzyme activity
[6,7]. Individuals with the MTHFR 677C>T homozygous
TT have only 25% of MTHFR enzyme activity, which
reduces plasma folate levels and elevates plasma homo-
cysteine levels. This homozygous TT genotype may con-
fer elevated plasma homocysteine levels, lifelong DNA
hypomethylation, and increased risk of cancer [8,9].
However, the homozygous TT genotype also can cause a
greater availability of 5,10-methylenetetrahydrofolate and
thymidine, increasing purine synthesis and leading to
smaller probability of DNA strand breakage [10,11].
Thus, the MTHFR 677C>T TT genotype may therefore
confer both an increased as well as decreased risk of
cancer [10,11]. Many case–control studies have been
published to assess the association between MTHFR
677C>T polymorphism and cervical cancer, but the avail-
able evidence for this genetic association is still weak,
owing to disagreements among the conclusions from
those studies [12-18]. Small genetic association studies
have various designs, different methodologies and insuffi-
cient power, and fail to demonstrate a strong correlation,
while combining data from all eligible studies by meta-
analysis has the advantage of reducing random error and
obtaining precise estimates for potential genetic associa-
tions [19,20]. To shed some light on this possible asso-
ciation between MTHFR 677C>T polymorphism and
cervical cancer, we presented herein the results of a meta-
analysis of published data. We followed the Meta-analysis
of Observational Studies in Epidemiology (MOOSE) con-
sensus statement during stages of design, implementation,
and reporting of this meta-analysis [21].
Methods
Search strategy
We conducted a comprehensive search in the Pubmed,
Embase, Web of Science, and Chinese Biomedical
Database (CBM) databases from their inception through
August 22, 2011 and updated on May 6, 2012. We com-
bined search terms for MTHFR 677C>T polymorphism
and cervical cancer. Search terms included: (Methylene-
tetrahydrofolate reductase, MTHFR, C677T, 677C>T, or
rs1801133); and (cervical carcinoma, cervical cancer, cer-
vical tumor, or cervix cancer). There was no language
limitation. All references cited in the included studies
were also reviewed to identify additional published arti-
cles not indexed in common databases.
Study eligibility
Eligibility criteria included the following: 1) case–control
design with genotyping of individuals with and without
cervical cancer 2) cervical cancer confirmed histologi-
cally or pathologically 3) sufficient reported genotypic
frequencies in both cases and controls for estimating anodds ratio (OR) with a 95% confidence interval (95%CI)
4) the genotype distribution among the control popula-
tion consistent with Hardy-Weinberg Equilibrium
(HWE). In studies with overlapping cases or controls,
only the largest study with extractable data was included
in the meta-analysis. Studies without relevant data
or about cervical intraepithelial neoplasia (CIN) were
excluded. Studies investigating cancer progression,
severity, phenotype modification, response to treatment,
or survival were excluded from this review. Family-based
association studies were also excluded due to differing
study designs.
Data extraction
Two investigators independently extracted data, and dis-
agreements were resolved through consensus. Standar-
dized abstraction sheets were employed for recording
data from individual studies. Data retrieved from these
studies included the following: author, year of publica-
tion, study design, study population, ethnicity of the
study population (categorized as Europeans, East Asians,
Indians, and others), demographics, genotyping method,
adjustment for known confounding variables (age, smoking,
alcohol consumption, folate, HPV status, etc.), and the
genotype distribution of MTHFR 677C>T polymorphism
in the cases and controls.
Quality assessment
Quality assessment of case–control studies in this meta-
analysis was performed using the Newcastle Ottawa
scale (NOS) as recommended by the Cochrane Non-
Randomized Studies Methods Working Group [22-24].
This instrument was developed to assess the quality of
nonrandomized studies, specifically cohort and case–
control studies. Based on the NOS, case–control studies
were judged based on three broad perspectives: selection
of study groups (1 criterion), comparability of study
groups (4 criteria), and ascertainment of outcome of
interest (3 criteria). Given the variability in quality of
observational studies found on our initial literature
search, we considered studies that met 5 or more of the
NOS criteria as high quality [22-24].
Statistical analysis
We performed a meta-analysis of the association
between MTHFR 677C>T polymorphism and cervical
cancer under the allele contrast (T versus C), homozy-
gote (TT versus CC), heterozygote (CT versus CC),
recessive (TT versus CT and CC), and dominant (TT
and CT versus CC) models. We calculated the pooled
OR with its corresponding 95%CI to assess this possible
association. The significance of the pooled OR was
determined by the Z test, and a P value of less than 0.05
was considered significant. In our study, two models of
Abstracts identified through literature search 
(n = 59) 
Full-text articles reviewed for more detailed 
evaluation (n = 18) 
41 abstracts excluded 
   Over lapping records (n = 36) 
   Obvious irrelevant studies (n = 5) 
Articles included in the meta-analysis (n = 11) 
7 articles excluded 
Cervical intraepithelial neoplasia (n = 2) 
No data available (n = 3) 
Overlapping study study (n = 1) 
Case only study (n = 1)
Figure 1 Flow chart of study selection in the meta-analysis of
MTHFR 677C>T polymorphism with cervical cancer.
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the random-effects model and the fixed-effects model
[25,26]. The random-effects model was performed, using
the DerSimonian and Laird’s method [26], while the
fixed-effects model was conducted using the Mantel-
Haenszel’s method [25]. To assess the between-study
heterogeneity more precisely, both the chi-square based
Q statistic test and the I2 statistic were calculated
[27,28]. I2 values of 25%, 50%, and 75% were used as
evidence of low, moderate, and high heterogeneity, re-
spectively [27]. The random-effects model was used to
pool the data when moderate heterogeneity existed;
however, the data were not pooled if high heterogeneity
existed (I2 value > 75%). In addition, the fixed-effects
model was used to pool the data when low heterogeneity
existed (I2 value < 50%). For additional analyses, the
cases and controls were subgrouped by ethnicity. Ethni-
city was firstly categorized into Caucasians, East Asians,
Africans, and others according to racial classifications
for genetic studies [30,31]. Caucasians were further
categorized into Europeans and Indians [30,31]. East
Asians mainly included China, Korea, and Japan. Be-
cause characteristics of participants were not consistent
between studies, we further conducted meta-regression
analysis to explore possible explanations for heterogen-
eity [29]. To validate the credibility of outcomes in this
meta-analysis, sensitivity analysis was performed by se-
quential omission of individual studies or by omitting
studies without high quality [32]. Potential publication
bias was assessed by visual inspection of the Begg’s fun-
nel plot, and a symmetric plot suggested low risk of pos-
sible publication bias [33]. In addition, we also
performed the Egger linear regression test at the P < 0.10
level of significance to assess the publication bias [34].
All analyses were performed using STATA version 12.0
(StataCorp LP, College Station, Texas). A P value < 0.05
was considered statistically significant, except where
specified.
Results
Characteristics of included studies
A flow diagram illustrating the study selection process
is shown in Figure 1. With our original search criterion,
59 abstracts were found. After discarding those which
did not meet the criteria clearly and excluding 41 records,
18 publications were preliminarily identified for further
detailed evaluation [12-18,35-45]. After reviewing each
original paper and extracting data, 7 publications were
excluded including two studies on CIN [36,41], three for
lack of available data [37-39], one for case-only study [35]
and one for overlapping study [40]. Following these exclu-
sions, 11 individual case–control studies with a total of 1,
898 cases and 2, 678 controls were included into this
meta-analysis [12-18,42-45].Table 1 presents a brief description of these 11 case–
control studies. Ethnic groups among these studies
were as following: 6 Caucasians, 4 East Asians and one
from the Mexican population. There were 3 studies in
Europeans [18,14, and 43] and 3 studies in Indians
[13,15, and 16]. All 11 studies were hospital-based case–
control studies. Five studies selected controls from
healthy individuals, five selected controls from non-
cancer individuals, and one selected controls from
non-cancer patients with hysteromyoma (Table 1). The
confounding factors were reported in 7 studies, and age
was the most common confounding factor (Table 1).
The number of cases varied from 21 to 636, and the
number of controls varied from 74 to 592 (Table 1).
The distribution of the MTHFR 677C>T genotype in the
control groups of these 11 studies was all consistent with
HWE (All P HWE values were more than 0.05, Table 1).
According to the quality criteria, there were 10 studies
of high quality, and one low quality (Table 1).
Meta-analysis
Table 2 shows the results of the association between
MTHFR 677C>T polymorphism and cervical cancer
(Table 2). Meta-analyses of the 11 studies showed no as-
sociation between MTHFR 677C>T polymorphism
and cervical cancer under the five genetic models (All
P values > 0.05, Table 2). Sensitivity analyses by sequen-
tial omission of individual studies or studies with low
quality did not materially alter the overall pooled ORs.
In subgroup analyses, the odds of finding the homozy-
gous TT genotype in subjects were much less in cases
than controls in Caucasians, which implied an associ-
ation between homozygous TT genotype and cervical
cancer in Caucasians (For TT versus CC: fixed-effects
OR = 0.63, 95%CI 0.45-0.88, P = 0.007; random-effects
able 1 Characteristics of studies on the association between MTHFR 677C>T polymorphism and cervical cancer
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Table 2 Odds ratios and heterogeneity results in the meta-analysis of the association between MTHFR 677C>T
polymorphism and cervical cancer
Contrast model Studies
(participants)
Fixed effects model Random effects model PH‡ I
2
(%)OR[95%CI]* POR OR[95%CI] POR
Total studies#
TT versus CC 11(4,576) 1.05(0.85-1.30) 0.644 1.06(0.72-1.56) 0.773 0.008 58.2%
CT versus CC 11(4,576) 0.81(0.70-0.92) 0.002 0.86(0.67-1.11) 0.247 0.002 63.5%
TT + CT versus CC 11(4,576) 0.83(0.73-0.95) 0.005 0.90(0.68-1.20) 0.481 <0.001 73.3%
TT versus CT + CC 11(4,576) 1.14(0.94-1.38) 0.171 1.14(0.84-1.54) 0.412 0.052 45.1%
Caucasians
T versus C 6(2,769) 0.74(0.65-0.84) <0.001 0.74(0.54-1.01) 0.056 0.004 71.0%
TT versus CC 6(2,769) 0.63(0.45-0.88) 0.007 0.64(0.45-0.89) 0.009 0.794 0.0%
CT versus CC 6(2,769) 0.69(0.58-0.82) <0.001 0.74(0.50-1.09) 0.122 0.003 71.7%
TT + CT versus CC 6(2,769) 0.68(0.58-0.80) <0.001 0.71(0.49-1.04) 0.082 0.003 72.8%
TT versus CT + CC 6(2,769) 0.73(0.52-1.01) 0.056 0.73(0.53-1.02) 0.067 0.871 0.0%
East Asians
T versus C 4(1,648) 1.24(1.07-1.44) 0.004 1.28(1.02-1.62) 0.034 0.092 53.5%
TT versus CC 4(1,648) 1.56(1.17-2.08) 0.003 1.66(1.05-2.62) 0.029 0.097 52.6%
CT versus CC 4(1,648) 1.08(0.85-1.37) 0.514 1.08(0.85-1.37) 0.518 0.754 0.0%
TT + CT versus CC 4(1,648) 1.20(0.96-1.50) 0.102 1.21(0.95-1.54) 0.120 0.340 10.6%
TT versus CT + CC 4(1,648) 1.51(1.17-1.94) 0.001 1.55(1.09-2.22) 0.016 0.157 42.4%
Europeans
T versus C 3(1,632) 0.77(0.66-0.89) 0.001 0.77(0.66-0.89) 0.001 0.828 0.0%
TT versus CC 3(1,632) 0.65(0.45-0.93) 0.020 0.65(0.45-0.93) 0.020 0.991 0.0%
CT versus CC 3(1,632) 0.71(0.58-0.88) 0.002 0.71(0.58-0.88) 0.002 0.552 0.0%
TT + CT versus CC 3(1,632) 0.70(0.58-0.86) <0.001 0.70(0.58-0.86) <0.001 0.658 0.0%
TT versus CT + CC 3(1,632) 0.75(0.53-1.07) 0.113 0.75(0.53-1.07) 0.113 0.922 0.0%
Indians§
TT versus CC 3(1,137) 0.51(0.20-1.30) 0.157 0.54(0.19-1.59) 0.260 0.321 12.0%
TT versus CT + CC 3(1,137) 0.57(0.22-1.46) 0.239 0.60(0.23-1.59) 0.305 0.471 0.0%
(*OR = Odds Ratio; 95%CI = 95% Confidence Interval; † random = random-effects model; fixed = fixed-effects model; ‡PH, the P value of heterogeneity; # the data
was not pooled in the analysis of the allele contrast model (T versus C) owing to the high heterogeneity (I2 = 79.8%); § the data was not pooled in the analyses of
the allele contrast model (T versus C, I2 = 87.7%), heterozygote (CT versus CC, I2 = 87.8%), and dominant (TT and CT versus CC, I2 = 88.5%) models owing to the
high heterogeneity.)
Mei et al. BMC Cancer 2012, 12:467 Page 5 of 9
http://www.biomedcentral.com/1471-2407/12/467OR = 0.64, 95%CI 0.45-0.89, P = 0.009; I2 = 0.0%)
(Figure 2, Table 2). However, the odds of finding the
homozygous TT genotype in subjects was greater in
cases than controls in East Asians, which also implied
an association between the homozygous TT genotype
and cervical cancer in East Asians (For TT versus CC:
random-effects OR = 1.66, 95%CI 1.05-2.62, P = 0.029,
I2 = 52.6%; For TT versus CT/CC: random-effects OR =
1.55, 95%CI 1.09-2.22, P = 0.016, I2 = 42.4%) (Figure 2,
Figure 3, Table 2). For the subgroup analysis of East
Asians, sensitivity analyses was further performed by ex-
cluding Ma et al.’s study which had low quality. Meta-
analysis of the three remaining studies showed the odds
of the homozygous TT genotype were still greater in
cases than controls in East Asians (For TT versus CC:
fixed-effects OR = 1.37, 95%CI 1.00-1.87, P = 0.050, I2 =
0.0%; For TT versus CT/CC: fixed-effects OR = 1.34,95%CI 1.01-1.77, P = 0.039, I2 = 0.0%), which further
indentified the association between the homozygous TT
genotype and cervical cancer in East Asians. In addition,
in the subgroup analysis of Europeans, there was no het-
erogeneity in any genetic models (All I2 = 0.0%, while the
pooled results suggested an association between MTHFR
677C>T polymorphism and cervical cancer in Europeans
under four genetic models (Table 2). However, no sig-
nificant association was found in the subgroup analysis
of Indians (Table 2).
Heterogeneity analysis
There was obvious heterogeneity in some genetic models
for both the 11 studies and subgroup analyses (Table 2).
Meta-regression analyses suggested ethnicity was the
major source of heterogeneity in this meta-analysis
under two comparison models (for TT versus CC,
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Figure 2 Forest plot shows an association between the MTHFR 677C>T homozygous TT genotype and cervical cancer (TT versus CC).
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Figure 3 Forest plot shows an association between the MTHFR 677C>T homozygous TT genotype and cervical cancer
(TT versus CT/CC).
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http://www.biomedcentral.com/1471-2407/12/467P = 0.048; for TT versus CT/CC, P = 0.045); however, no
other sources were found by meta-regression analyses.
Multivariate analyses of meta-regression were also per-
formed, but no further definite source of heterogeneity
were identified.
Publication bias
Begg’s funnel plot and Egger’s test were used to assess
the publication bias in this meta-analysis. The Funnel
plots’ shape of all contrasts did not reveal obvious evi-
dence of asymmetry, and all the P values of Egger’s test
were more than 0.05, providing statistical evidence for
the funnel plots’ symmetry. For example, in the meta-
analysis investigating the association between MTHFR
677C>T polymorphism and cervical cancer under the
allele contrast model (T versus C), the funnel plot’s
shape was symmetrical, suggesting no presence of publi-
cation bias (Figure 4); in addition, the P value of the
Egger’s test for the allele contrast model was 0.744, pro-
viding statistical evidence for funnel plot symmetry.
Thus, the above results suggest that publication bias was
not evident in this meta-analysis.
Discussion
Many case–control studies have been published to assess
the association between MTHFR 677C>T polymorphism
and cervical cancer, but the available evidence is
still weak owing to disagreements among those studies
[12-18]. Also, no meta-analysis assessing the association
between MTHFR 677C>T polymorphism and cervical
cancer has been performed. Thus, there is a need to per-
form a meta-analysis of published data investigating the
association between MTHFR 677C>T polymorphism
and cervical cancer to shed light on the contradictory











Figure 4 Begg’s funnel plot for assessing the publication bias risk unbetween MTHFR 677C>T polymorphism and cervical
cancer was based on 11 studies, which gave a larger
set of data for detecting significant differences. Meta-
analyses of these 11 studies showed that there was no
association between MTHFR 677C>T polymorphism
and cervical cancer under any of the five genetic models
(All P values > 0.05). However, subgroup analyses
showed the odds of finding a homozygous TT genotype
in subjects was much less in cases than controls in Eur-
opeans while the odds of finding the homozygous TT
genotype was greater in cases than controls in East
Asians, which implied an association between homozy-
gous TT genotype and cervical cancer. Meta-regression
analyses suggested ethnicity was the major source of
heterogeneity in this meta-analysis. Publication bias was
not evident in this meta-analysis. Thus, these findings
support an association between MTHFR 677C>T poly-
morphism and cervical cancer, and there may be a race-
specific effect in this association.
Several large-scale meta-analyses combining data from
multiple studies have been published investigating the
association between MTHFR 677C>T polymorphism
and various cancers such as gastric cancer, lung cancer,
breast cancer, colorectal cancer, and liver cancer
(Figure 5) [11,46-51]. Mazaki et al. and Jin et al.
reported no association between liver and pancreatic
cancers and MTHFR 677C>T polymorphism [47,49].
Zhang et al. reported the MTHFR 677C>T homozygous
TT genotype may be associated with gastric cancer
among Asians but not in Europeans [51]. However,
Taioli et al. found that the MTHFR 677C>T homozy-
gous TT genotype was associated with colorectal cancer
among both Asians and Europeans [50]. Zacho et al.
reported an association between MTHFR 677C>T the
homozygous TT genotype and any site cancer in Asiansdence limits
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Figure 5 Summary of the associations between MTHFR 677C>T polymorphism and different cancers (data were extracted from
meta-analyses published previously [11,46-51] and present meta-analysis).
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the occurrence of the MTHFR 677C>T homozygous TT
genotype is much less common in cases than controls
in Europeans, but is greater in cases than controls in
East Asians, which implies an association between
MTHFR 677C>T polymorphism and cervical cancer.
Thus, MTHFR 677C>T polymorphism may exert differ-
ent effects in different kinds of cancer, and there might
be race-specific effect in those associations.
Heterogeneity is a very important part of meta-
analysis, and finding the possible sources for the high
heterogeneity is very important and can greatly affect
the results of a meta-analysis [52]. To explore the pos-
sible sources for the high heterogeneity in present meta-
analysis, we performed two steps including subgroupanalysis and meta-regression analysis. By subgroup ana-
lysis and meta-regression analysis, we found ethnicity
was the major source of the high heterogeneity in our
meta-analysis, which could be explained by the race-
specific effect of MTHFR 677C>T polymorphism on sus-
ceptibility to cervical cancer. However, ethnicity didn’t
explain all heterogeneity in this meta-analysis, and no
other sources were found by meta-regression analysis.
MTHFR regulates the metabolism of folate, and it is
an important factor in DNA methylation and synthesis.
Both heterozygous and homozygous variants of MTHFR
677C>T polymorphism have reduced MTHFR enzyme
activity compared with the homozygous normal wild-
type genotype. Reduction of MTHFR enzyme activity
can increase the pool of 5, 10-methylene-THF at the
Mei et al. BMC Cancer 2012, 12:467 Page 9 of 9
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methylation. Because DNA methylation plays a critical
role in regulation of gene expression and maintenance of
genomic stability, the aberrations in normal methylation
patterns caused by MTHFR 677C>T polymorphism
might further result in the development of cervical
cancer by impairing the DNA methylation. Thus, there is
also biological evidence for the association between
MTHFR 677C>T polymorphism and cervical cancer. Our
meta-analysis further provides epidemiological evidence
for the association above. In addition, there is another
common polymorphism in the MTHFR gene known as
MTHFR 1298A>C polymorphism. MTHFR 1298A>C
polymorphism is also associated with reduced levels of
MTHFR enzyme and related to hyperhomocysteinemia,
and it may also be associated with the development of
cervical cancer [53]. However, there are only two case–
control studies published to assess the association between
MTHFR 1298A>C polymorphism and cervical cancer
[40,42], and neither find an association. This lack of asso-
ciation may result from the limited sample size reflected
in those two studies, and further studies with larger
sample sizes are needed to identify this possible association.
Our analysis has several limitations that should be
considered when interpreting the findings. Firstly, the
main limitation of the meta-analysis was the inclusion of
only a few studies with relatively small sample sizes and
poor validation. There were only four studies from East
Asian and three studies from Europeans. In addition,
though we used two methods to assess the publication
bias, these two methods may be limited in effectiveness
for detecting the risk of publication bias, especially with
the limited number of included studies. Thus, more
studies with large sample sizes and careful design are
needed to further identify this association more compre-
hensively. Secondly, our main analysis was based on un-
adjusted estimates owing to the lack of available data.
However, a more precise analysis could be performed if
adjusted estimates were available in all studies [54]. Fur-
thermore, variability in the study designs and the selec-
tion of controls was revealed in present meta-analysis.
Though we found that ethnicity was one major source of
the high heterogeneity and could explain part of the high
heterogeneity, no other sources were found. To get
results from meta-analysis of homogeneous studies,
more studies with homogeneously constructed design
are needed in the future. Thirdly, the association be-
tween MTHFR 677C>T polymorphism and cervical can-
cer may be affected by the different histological types of
cervical cancer. However, little data on this aspect were
reported in the included studies, and we were unable to
make subgroup analyses by histological type. Further
studies are needed to identify this association in different
histological types of cervical cancer. Finally, gene-geneand gene-environmental factors interactions were not
fully addressed in this meta-analysis due to the lack of
sufficient data. Previous study suggested an association
between methylation of CpG sites in the HPV genome
(particularly in L2 and L1) and diagnosis of CIN3, as
compared to viral clearance, and the MTHFR gene may
have a potential effect on cervical cancer by impairing
DNA methylation not only in the host genes but also on
the viral genes [55]. Thus, the association between
MTHFR 677C>T polymorphism and cervical cancer
could be affected by host HPV status, and there is high
probability of gene-HPV interaction effects. In addition,
several other gene polymorphisms are also associated
with cervical cancer, and there may be gene-gene inter-
actions [4,56]. Future studies may further assess the pos-
sible gene-gene and gene-environmental interactions in
the association between MTHFR 677C>T polymorphism
and cervical cancer.
Conclusions
In conclusion, our meta-analysis supports an association
between MTHFR 677C>T polymorphism and cervical
cancer, and there may be a race-specific effect in this
association. In addition, further studies with larger
sample sizes and careful design are needed to identify
this association more comprehensively.
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